In the past decade significant contributions have been made to the understanding of acute glomerulonephritis by virtue of advances in many fields, including epidemiology, immunology ...

Pauci-immune focal necrotizing glomerulonephritis (FNGN) characteristically occurs in the context of antineutrophil cytoplasmic antibody (ANCA)-associated small-vessel vasculitis ().Writing in ...

introduction导读伴单克隆免疫球蛋白沉积的增值性肾小球肾炎（PGNMID）是一种可以累及肾脏的病变。2004年Nasr提出，PGNMID应归为单克隆免疫球蛋白病（MGRS）。在这种疾病中，单克隆免疫球蛋白会沉积在肾小球中，从而引起补体激活、 ...

Are you searching for medications to treat 'Glomerulonephritis'? Welcome to this page which serves as an archive for medications that are relevant to the treatment of Glomerulonephritis.

Targeting T cells with ustekinumab is a potential therapeutic strategy for AAV-GN that merits additional evaluation in ...

The following is a summary of “Minimal change glomerular disease associated with solid neoplasms: a systematic review,” ...

Apellis is ready for growth in the US market with SYFOVRE and has a strong cash position to support future efforts. Learn ...

WA cases of a kidney disease which most commonly affects children following a skin or throat infection has doubled in the ...

Chronic kidney disease (CKD), sometimes called chronic kidney failure, means that kidneys are irreversibly damaged, and the ...

NS Pharma, Inc. (NS Pharma), a subsidiary of Nippon Shinyaku Co., Ltd. (Nippon Shinyaku), announced that the Galactic53 study of VILTEPSO® (generic name: viltolarsen) – a treatment for Duchenne ...

Data presentations highlight the results for FILSPARI®(sparsentan), the only approved kidney-targeted medicine for IgA nephropathy, when used as ...